Worth reading
56In focus
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
-45.5
% (year-on-year change in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
Q11 July 2026 to 30 September 2026ConsolidatedJapanese GAAPNet Sales31,454¥ millionYear on year +2.0%Progress 17.6%
Operating profit141¥ millionYear on year -45.5%Progress 7.1%
Ordinary income122¥ millionYear on year -52.2%Progress 6.3%
Net income attributable to owners of the parent36¥ millionYear on year -77.9%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥5.24
Financial position at period-end
Total assets74,152¥ million
of which net assets 20,844 ¥ millionEquity ratio 28.1%vs. prior year-end +0.1pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueMedical Equipment Business ¥29,557 million (YoY +1.6%), SPD Business ¥1,608 million (YoY +8.4%), Nursing Care Products Business ¥764 million (YoY +5.9%)
Segment profitMedical Equipment Business ¥131 million (YoY -40.5%), SPD Business ¥37 million (YoY +80.0%), Nursing Care Products Business ¥55 million (YoY +5.3%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥178,885 million (YoY +41.3%)
Operating profit¥1,986 million (YoY +18.3%)
Ordinary income¥1,950 million (YoY +17.2%)
Profit attributable to owners of the parent¥1,172 million (YoY +5.4%)
Revision to Earnings ForecastNet Sales Undecided → ¥178,885 million / Operating profit Undecided → ¥1,986 million / Ordinary income Undecided → ¥1,950 million / Profit attributable to owners of the parent Undecided → ¥1,172 million
Annual Dividend Forecast80 Yen → 80 Yen（0.0%）
Factors Behind Changes in Business Performance
Operating profit decreased due to one-off expenses, including salary base increases, system investments to promote digital transformation, and fees related to the business integration. Factors affecting changes in performance included additional personnel and system investments in the Medical Equipment Business, temporary cost reductions resulting from procurement policies in the SPD Business, and growth in the rental business and sales of goods in the Nursing Care Products Business.
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 2 / Company name DVx Inc., 総合医療サービス株式会社 / Excluded Number of companies 0 / Company name Not disclosed
Impairment lossNone
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Loss on disposal of property, plant and equipment ¥15,301 thousand, Loss on disposal of intangible assets ¥1,296 thousand, Total extraordinary losses ¥16,597 thousand
Depreciation and amortization¥170,990 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End10,653,178 Shares
Treasury Shares at Period-End322,272 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Q1 |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 July 2026 to 30 September 2026 |
| Net Sales | ¥31,454 million (YoY +2.0%) |
| Operating profit | ¥141 million (YoY -45.5%) |
| Ordinary income | ¥122 million (YoY -52.2%) |
| Profit attributable to owners of the parent | ¥36 million (YoY -77.9%) |
| Net income per share | ¥5.24 |
| Equity ratio | End of the current fiscal period 28.1 / End of previous period 28 |
| Total assets | ¥74,152 million |
| Net assets | ¥20,844 million |
| Full-year earnings forecast | Net Sales ¥178,885 million (YoY +41.3%) / Operating profit ¥1,986 million (YoY +18.3%) / Ordinary income ¥1,950 million (YoY +17.2%) / Profit attributable to owners of the parent ¥1,172 million (YoY +5.4%) |
| Revision to Earnings Forecast | Net Sales Undecided → ¥178,885 million / Operating profit Undecided → ¥1,986 million / Ordinary income Undecided → ¥1,950 million / Profit attributable to owners of the parent Undecided → ¥1,172 million |
| Annual Dividend Forecast | 80 Yen → 80 Yen（0.0%） |
| Segment revenue | Medical Equipment Business ¥29,557 million (YoY +1.6%), SPD Business ¥1,608 million (YoY +8.4%), Nursing Care Products Business ¥764 million (YoY +5.9%) |
| Segment profit | Medical Equipment Business ¥131 million (YoY -40.5%), SPD Business ¥37 million (YoY +80.0%), Nursing Care Products Business ¥55 million (YoY +5.3%) |
| Depreciation and amortization | ¥170,990 thousand |
| Impairment loss | None |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Loss on disposal of property, plant and equipment ¥15,301 thousand, Loss on disposal of intangible assets ¥1,296 thousand, Total extraordinary losses ¥16,597 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 2 / Company name DVx Inc., 総合医療サービス株式会社 / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 10,653,178 Shares |
| Treasury Shares at Period-End | 322,272 Shares |
| Factors Behind Changes in Business Performance | Operating profit decreased due to one-off expenses, including salary base increases, system investments to promote digital transformation, and fees related to the business integration. Factors affecting changes in performance included additional personnel and system investments in the Medical Equipment Business, temporary cost reductions resulting from procurement policies in the SPD Business, and growth in the rental business and sales of goods in the Nursing Care Products Business. |
Items this document does not state (10)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company reported that operating profit fell below the year-earlier level due to one-off expenses, including salary base increases, system investments to promote digital transformation, and fees related to the business integration. It also explained that medical institutions remain cautious about capital investment because of severe labor shortages and persistently high costs.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.